Respiratory administration of measles vaccine

With 279 000 reported cases and 197 000 deaths per year, measles continues to be an important cause of childhood morbidity and mortality, especially in low-income countries.1 In 2008, the World Health Assembly reaffirmed the goal to reduce mortality from measles by more than 90% in 2010, compared with rates from 2000.2 Moreover, WHO\'s executive board has instructed its organisation to explore the feasibility of global measles elimination. Programmatic and technological innovation will be needed to sustain recent successes in reduction of the global burden of measles.